Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California

Hepatology

Volumn 25, Issue 1, 1997, Pages 226-228

  Yu, Mimi C ^a,b   Yuan, Jian Min ^a   Ross, Ronald K ^a   Govindarajan, Sugantha ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEROLOGY; UNITED STATES;

EID: 0031021382     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250141     Document Type: Article

References (15)

1. Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J, eds. Cancer incidence in five continents. Volume 6. Lyon: IARC Scientific Publications No. 120, 1992.
2. Yeh F-S, Yu MC, Mo C-C, Luo S, Tong MJ, Henderson BE. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 1989;49:2506-2509.
3. Lam KC, Yu MC, Leung JWC, Henderson BE. Hepatitis B virus and cigarette smoking - risk factors for hepatocellular carcinoma in Hong Kong. Cancer Res 1982;42:5246-5248.
4. Ross RK, Yuan J-M, Yu MC, Wogan GN, Qian G-S, Tu J-T, Groopman JD, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992;339:943-946.
5. Kliman A, Reid NR, Lilly C, Morrison J. Hepatitis-associated antigen (Australia antigen) in Massachusetts blood donors. N Engl J Med 1971;285: 783-785.
6. Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990;82:1038-1041.
7. Choo Q-L, Kuo G, Weiner A, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
8. Hadziyannis S, Tabor E, Kaklamani E, Tzonou A, Stuver S, Tassopoulos N, Mueller N, et al. A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma. Int J Cancer 1995;60: 627-631.
9. Suga M, Senota A, Arima K, Kodama T, Ikuta S, Sakamoto H, Ohe Y, et al. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma. Hepatogastroenterology 1994;41:438-441.
10. Cenac A, Pedroso ML, Djibo A, Develoux M, Pichoud C, Lamothe F, Trepo C, et al. Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger. Am J Trop Med Hyg 1995;52:293-296.
11. Johnson PJ, Williams R. Hepatitis C antibodies and hepatocellular carcinoma: new clues or a false trail? J Natl Cancer Inst 1990;82:986-987.
12. Bernstein L, Ross RK. Cancer in Los Angeles county. A portrait of incidence and mortality 1972-1987. Los Angeles: University of Southern California, 1991.
13. Kaneko S, Feinstone S, Miller R. Rapid and sensitive method for the detection of serum hepatitis B virus DNA using polymerase chain reaction technique. J Clin Microbiol 1989;27:1930-1933.
14. Breslow NE, Day NE. Statistical methods in cancer research. Volume 1 - The analysis of case-control studies. Lyon: IARC Scientific Publications No. 32, 1980.
15. Yu MC, Tong MJ, Govindarajan S, Henderson BE. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-1826.